Effect of Drug
Conditions
Brief summary
The primary aim of this clinical trial is to compare the effectiveness of fentanyl vs morphine as analgosedation in mechanically ventilated adult patients in the ICU. This study also aims to compare the outcomes of patients between the two groups. The main questions it aims to answer are : 1. Does propofol and fentanyl infusion as analgo-sedation achieve targeted sedation score at 12 and 24 hours compared to propofol and morphine infusion in mechanically ventilated adult patients in the intensive care unit (ICU)? 2. Is there a difference between the proportion of patients requiring rescue sedation dose between the fentanyl and morphine groups?
Detailed description
Researchers will randomize patients into 2 groups (Fentanyl and Morphine) and will start study drug accordingly for sedation in ICU.Proportion of patients from each group achieving targeted sedation score at 12 and 24 hours following initiation of the drug and proportion of patients from each group requiring rescue sedation dose will be recorded and analyzed. Furthemore duration of mechanical ventilation, length of ICU stay and 14 days mortality rate will recorded and compared between this 2 groups of patients.
Interventions
DRUGFentanyl
Intravenous fentanyl infusion with dilution of 10mcg/ml
DRUGMorphine
Intravenous morphine infusion with dilution 1mg/ml
Sponsors
Universiti Sains Malaysia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
Randomized control trial, two arms
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age \>18 years old * Patients who are expected by the ICU team to require invasive mechanical ventilation in ICU for at least more than 24 hours and for whom the ICU team decides to initiate continuous infusion of sedation * A patient who was ventilated and sedated not more than 12 hours before ICU admission.
Exclusion criteria
* Patients with chronic use of narcotics * Patients with chronic liver failure or end-stage renal failure * Patients with severe chronic neurocognitive dysfunction * Patients with drug overdose * Patients with a known allergy to either morphine or fentanyl * Patients who are receiving neuromuscular blockers * Patients who are pregnant * Patients who are diagnosed to have severe traumatic brain in
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| RASS score at 12 and 24 hours | 24 hours from study drug initiation | To determine the proportion of patients achieving the targeted sedation guided by RASS score at 12 and 24 hours in both fentanyl and morphine group. |
| Rescue sedation doses | 24 hours from study drug initiation | To determine the proportion of patients requiring rescue sedation doses between fentanyl and morphine group |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Duration of mechanical ventilation | 90 Days | To compare the duration of mechanical ventilation between the fentanyl and morphine groups |
| Length of ICU stay | 90 days | To compare the length of ICU stay between the fentanyl and morphine groups |
| 14 days mortality rate | 14 days from randomization | To compare 14-day mortality rates between the fentanyl and morphine groups |
Countries
Malaysia
Contacts
Primary ContactMohd Zulfakar Mazlan Dr, MBBS
Backup ContactSaravana Raj Joseph, MD
Outcome results
None listed